An internet-based cross-sectional study on infection control practices and drug use for COVID-19 prevention in Nigerian adultsArticle Published on 2022-06-012023-07-10 Journal: The Pan African Medical Journal [Category] COVID19(2023년), [키워드] Anti-bacterial agents Antimalarials COVID-19 infection control Ivermectin Masks Nigeria pharmaceutical preparations plant preparations. [DOI] 10.11604/pamj.2022.42.85.31596 PMC 바로가기
Quantitative analysis of favipiravir and hydroxychloroquine as FDA-approved drugs for treatment of COVID-19 using synchronous spectrofluorimetry: application to pharmaceutical formulations and biological fluids동시 분광형광법을 사용한 COVID-19 치료를 위한 FDA 승인 약물인 favipiravir 및 hydroxychloroquine의 정량 분석: 제약 제제 및 생물학적 유체에 적용Article Published on 2022-06-012022-09-11 Journal: Luminescence : the journal of biological and chemi [Category] COVID19(2023년), SARS, 치료기술, [키워드] Acetate acute respiratory syndrome Analysis applied approach biological fluid biological fluids buffer cause caused condition contagious coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 country COVID-19 Detection limit diluent drug Drug administration Ethanol exhibited Favipiravir FDA-approved drug fluorescence intensity food harmonization Healthcare systems human plasma sample human plasma samples Hydroxychloroquine identify information Interference International Conference investigated limit limits medications Pharmaceutical Preparation pharmaceutical preparations quantitation SARS-CoV-2 sensitivity Severe acute respiratory syndrome synchronous synchronous fluorimetry. Treatment United State United States United States Food and Drug Administration viral infection were measured [DOI] 10.1002/bio.4240 PMC 바로가기 [Article Type] Article
Pharmacy responses during the COVID-19 pandemic: a questionnaire surveyResearch Published on 2022-01-252022-10-28 Journal: BMC Public Health [Category] COVID-19, SARS, [키워드] adopted affected change coronavirus Coronavirus disease 2019 COVID-19 COVID-19 pandemic Disinfection ENhance equipment Ethanol evaluate for disinfection future infection hospital Infection infection control Japan local government measure Measures online tool Personal protective equipment pharmaceutical preparations Pharmacy physical distancing Prevent preventive measures public health questionnaire respond response Result Spread spreads surveys and questionnaires [DOI] 10.1186/s12889-022-12589-z PMC 바로가기 [Article Type] Research
Implementation of a novel home delivery service during pandemicArticle Published on 2021-11-012023-07-05 Journal: European Journal of Hospital Pharmacy [Category] SARS, [키워드] economics hospital hospital distribution systems medication systems pharmaceutical pharmaceutical preparations pharmacy service [DOI] 10.1136/ejhpharm-2020-002500 PMC 바로가기
l -Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in Cellsl-아르기닌은 루틴의 용해도 및 ANTI SARS-CoV-2 Mpro 활성을 개선하지만 세포의 항바이러스 활성은 개선하지 않습니다Article Published on 2021-10-072022-09-10 Journal: Molecules [Category] SARS, 신약개발, 치료제, [키워드] l-arginine activity anti-SARS-CoV-2 arginine cellular COVID-19 pandemic drug in silico inhibitor main protease mixture outbreak pharmaceutical preparations pharmacokinetic pharmacological quercetin rutin SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 Mpro solubility starting point Test water [DOI] 10.3390/molecules26196062 PMC 바로가기 [Article Type] Article
Liquid Chromatographic Methods for COVID-19 Drugs, Hydroxychloroquine and ChloroquineCOVID-19 약물, 하이드록시클로로퀸 및 클로로퀸에 대한 액체 크로마토그래피 방법Review Published on 2021-08-182022-09-11 Journal: Journal of chromatographic science [Category] SARS, 치료기술, 치료제, [키워드] 4-aminoquinoline Arthritis Autoimmune diseases biologic biological fluid biological fluids Chloroquine clinical trial clinical trials Complete country Course COVID-19 Determination doctor drug epidemiological studies facilitate HCQ Hydroxychloroquine information liquid lupus erythematosus malaria metabolite Patient pharmaceutical preparations Pharmacodynamics pharmacokinetics provide reported Research rheumatoid arthritis Safe supervision systemic lupus erythematosus Treatment treatment regimen [DOI] 10.1093/chromsci/bmaa110 PMC 바로가기 [Article Type] Review
Medication of Hydroxychloroquine, Remdesivir and Convalescent Plasma during the COVID-19 Pandemic in Germany—An Ethical AnalysisArticle Published on 2021-05-262022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] Affect Analysis analyzed assist Clinical ethics clinical setting clinical study conditions convalescent plasma COVID-19 COVID-19 pandemic disease outbreak distribution drug early stage Effect Epidemic ethical guideline excluded expand facilitate Germany group groups inclusion criteria maintain Medicine off-label pandemic Patient Perspective pharmaceutical preparations public health reaction reduce Remdesivir Repurposed drug SARS-CoV-2 Treatment use of hydroxychloroquine [DOI] 10.3390/ijerph18115685 PMC 바로가기 [Article Type] Article
Observational study on off-label use of tocilizumab in patients with severe COVID-19중증 COVID-19 환자에서 토실리주맙의 오프라벨 사용에 대한 관찰 연구Observational Study Published on 2021-01-012022-09-11 Journal: European Journal of Hospital Pharmacy [Category] 임상, 진단, 치료제, [키워드] 95% CI age Alanine alanine aminotransferase aspartate Aspartate aminotransferase average respiratory rate baseline best binding C-reactive protein candidate carried caused clinical conditions clinical impact clinical medicine cohort study collected control group Course COVID-19 Critical Critical care CRP cytokine Cytokine storm cytolysis deaths diagnosed with COVID-19 Efficacy Fewer patient Fewer patients Follow-up France Gender greater decrease had more Hospital stay hyperinflammation IL-6 IL-6 receptor impairment Inclusion infected with COVID-19 Inflammatory inhibit initial interleukin interleukin 6 interleukin 6 (IL-6) Intubated laboratory parameter Laboratory parameters lack less Ligand limit lung damage mechanical ventilation Novel coronavirus Observational cohort study observational study off-label off-label use oxygen oxygen supplementation Oxygen therapy pandemic Paris Patient pharmaceutical preparations Potential treatment pulmonary impairment pulmonary medicine Randomised clinical trials required respiratory respiratory rate SARS-CoV-2 SARS-COV-2 infection severe COVID-19 significant decrease significant difference Spread symptoms of COVID-19 syndrome TCZ the cytokine storm the disease the patient therapy Tocilizumab treated treated patient treated patients two groups Virology [DOI] 10.1136/ejhpharm-2020-002414 PMC 바로가기 [Article Type] Observational Study